Fluorouracil is not recommended for use in patients known to have certain homozygous or compound heterozygous DPYD variants that result in complete DPD deficiency. The Food and Drug Administration ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi USA, LLC is voluntarily recalling two lots of Fluorouracil Injection, USP 5g/100mL (50mg/mL), 100mL fill in 100mL vials, to the user level due to the ...

The drug is indicated for the treatment of patients with adenocarcinoma of the colon and rectum, adenocarcinoma of the breast, gastric adenocarcinoma and pancreatic adenocarcinoma. Alembic has ...

Fresenius Kabi USA, LLC is voluntarily recalling 2 lots of Fluorouracil Injection, USP 5g/100mL (50mg/mL), 100mL fill in 100mL vials, due to the potential for glass particulate. The recalled products, ...

Teva Parenteral Medicines has initiated a nationwide recall of six more lots of fluorouracil injection (Adrucil) because of the potential presence of particulate matter identified as an "aggregate of ...

Teva Parenteral Medicines has issued a voluntary recall of eight lots of fluorouracil injection USP (Adrucil) 5 g/100 mL (50 mg/mL). The reason cited is the potential presence of particulate matter, ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor, nurse or pharmacist. DBL Fluorouracil Injection BP contains the active ingredient ...

Cancer Control at the District Hospital Level in Sub-Saharan Africa: An Educational and Resource Needs Assessment of General Practitioners Gastric cancer (GC) is the fourth most common cancer and the ...